Evidence map›Paper›PMID 40862427›Full record

ArticleArquivos brasileiros de cardiologia2025

REBECGA: Brazilian Registry of Heart Disease and Pregnancy. Multicenter Epidemiological Study of Heart Diseases in Pregnancy: Retrospective Cohort.

Walkiria Samuel Avila, Alexandre Jorge Gomes de Lucena, Claudia Maria Vilas Freire, Fabio Bruno da Silva, Ivan Romero Rivera, Juliana Rodrigues Soares Oliveira, Maria Alayde Mendonça Rivera, Regina Coeli de Carvalho, Vicente Avila Neto, Flávio Tarasoutchi

Abstract readMulticenter Study
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Walkiria Samuel AvilaInstituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brasil.ORCID 0000-0001-5686-7058
Alexandre Jorge Gomes de LucenaHospital Agamenon Magalhães, Recife, PE - Brasil.
Claudia Maria Vilas FreireUniversidade Federal de Minas Gerais, Belo Horizonte, MG - Brasil.
Fabio Bruno da SilvaInstituto Dante Pazzanese de Cardiologia, São Paulo, SP - Brasil.
Ivan Romero RiveraUniversidade Federal de Alagoas Faculdade de Medicina, Maceió, AL - Brasil.
Juliana Rodrigues Soares OliveiraUniversidade Federal de Minas Gerais, Belo Horizonte, MG - Brasil.
Maria Alayde Mendonça RiveraUniversidade Federal de Alagoas Faculdade de Medicina, Maceió, AL - Brasil.ORCID 0000-0003-3322-0459
Regina Coeli de CarvalhoSecretaria de Estado da Saúde do Ceará (SESA), Fortaleza, CE - Brasil.ORCID 0000-0003-4075-3704
Vicente Avila NetoHospital do Servidor Público Municipal, São Paulo, SP - Brasil.
Flávio TarasoutchiInstituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brasil.ORCID 0000-0002-9964-3289

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeart disease, which affects approximately 4% of pregnancies, is the leading non-obstetric cause of maternal death. It is estimated that 40% of these deaths could be prevented with a better understanding of pregnancy risks.

objectivesTo develop the Brazilian Registry of Heart Diseases in Pregnancy (REBECGA) to study the prevalence, complications, and maternal mortality associated with heart diseases during pregnancy and postpartum.

methodsA multicenter retrospective study of pregnancy and postpartum follow up until 12 months after delivery in women with heart diseases, including analysis of predictive variables for maternal outcomes. A two-tailed significance level of 5% was adopted for statistical analysis.

resultsA total of 638 pregnant women were included, with the following diagnoses: valvular disease (37.8%), congenital heart diseases (35.7%), arrhythmias without structural heart damage (14.7%), cardiomyopathies (11.3%), and other heart diseases (6.4%). The main complications were heart failure (16.7%), arrhythmia (10.7%), and syncope (8.0%), with 18 maternal deaths (2.8%), 10 of which occurred during the postpartum period. Cesarean delivery was indicated in 62.9% of cases, with 25.7% preterm births and 3.2% fetal losses. Multivariate analysis identified WHO class IV risk classification (OR 3.51; 95% CI 1.75-7.04; p < 0.001); NYHA class III/IV (OR 2.27; 95% CI 1.12-4.60; p = 0.023), and pulmonary hypertension (OR 2.45; 95% CI 1.05-5.70; p = 0.037) as predictive variables for maternal complications and deaths.

conclusionsREBECGA highlighted the prevalence of valvular disease, heart failure as the main complication, the postpartum period as a critical time for maternal deaths, and identified predictive risk variables for adverse pregnancy outcomes in women with heart disease.

Indexed as

Heart DiseasesPregnancy Complications, CardiovascularAdultBrazilFemaleHumansMaternal MortalityPregnancyPregnancy OutcomePrevalenceRegistriesRetrospective StudiesRisk FactorsYoung Adult

Identifiers

PMID40862427
PMCPMC12677860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.